
Akoya Biosciences Investor Relations Material
Latest events

Q3 2024
Akoya Biosciences
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Akoya Biosciences Inc
Access all reports
Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research. The company offers DyScribe In Situ Protein Synthesis Kit for in situ protein synthesis to enable scientists to study the proteome; and Akoya Preclinical, which is an in vivo visualization and signaling platform that enables scientists to visualize and precisely measure signal activation at the single cell level. It also provides Akoya XSpatial Platform for research, diagnostics, and bio-manufacturing applications. The company was founded in 2011 and is headquartered in Cambridge, Massachusetts.
Latest articles
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
)
Bob Iger: Disney's Visionary CEO
Bob Iger is a legend in the entertainment industry, known for his visionary leadership and as one of the most influential CEOs in Disney's history.
10 Mar 2025
Ticker symbol
AKYA
Country
🇺🇸 United States